Expression and prognostic significance of programmed death-ligand 1 (PD-L1) in Merkel cell carcinoma

Simple item page
dc.contributor.authorRichter Igorcs
dc.contributor.authorJirásek Tomášcs
dc.contributor.authorČermáková Evacs
dc.contributor.authorBartoš Jiřícs
dc.contributor.authorBuchler Tomášcs
dc.contributor.authorDvořák Josefcs
dc.date.accessioned2020-06-08T09:45:35Z
dc.date.available17-41-2019en
dc.date.available2020-06-08T09:45:35Z
dc.date.issued2019cs
dc.date.updated28-26-2020en
dc.format.extent6cs
dc.identifier.issn1107-0625cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/156199
dc.language.isoengcs
dc.publisherZerbinis Medical Publicationscs
dc.publisher.cityGreececs
dc.relation.ispartofJBUON 2019 - Journal of Balkan Union of Oncologyen
dc.relation.ispartofseries0cs
dc.subjectMerkel cell carcinomacs
dc.subjectprognostic factorscs
dc.subjectoverall survivalcs
dc.subjectPD-L1cs
dc.subjectimmunotherapycs
dc.titleExpression and prognostic significance of programmed death-ligand 1 (PD-L1) in Merkel cell carcinomaen
dc.titleExpression and prognostic signi cance of programmed death- ligand 1 (PD-L1) in Merkel cell carcinomacs
local.citation.epage2155-2160cs
local.citation.spage2155-2160cs
local.identifier.publikace6902
local.relation.issue5cs
Files
Collections